These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1284829)

  • 1. [Value of alpha subunit assay in pituitary pathology].
    Morange I; Figarella-Branger D; Gunz G; Brue T; Jaquet P
    Ann Endocrinol (Paris); 1992; 53(4):138-46. PubMed ID: 1284829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of alpha-subunit hypersecretion in patients with pituitary tumors: clinically nonfunctioning and somatotroph adenomas.
    Oppenheim DS; Kana AR; Sangha JS; Klibanski A
    J Clin Endocrinol Metab; 1990 Apr; 70(4):859-64. PubMed ID: 1690748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoprotein hormone alpha-subunit secretion in prolactinomas and in non-functioning adenomas: relation with the tumour size.
    Warnet A; Porsova-Dutoit I; Lahlou N; Seret-Begue D; Lajeunie E; Chanson P; Woimant F; Lot G; Guillausseau PJ; Roger M
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):177-84. PubMed ID: 7523001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
    Popovic V; Damjanovic S
    Thyroid; 1998 Oct; 8(10):935-9. PubMed ID: 9827662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.
    Blanco C; Lucas T; Alcañiz J; Davila N; Serrano P; Barcelò B; Estrada J
    J Endocrinol Invest; 1994 Feb; 17(2):99-104. PubMed ID: 8006339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-secreting pituitary adenomas: report of seven cases.
    Beckers A; Abs R; Mahler C; Vandalem JL; Pirens G; Hennen G; Stevenaert A
    J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
    Kwekkeboom DJ; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood serum concentrations of gonadotropins and α-subunit in patients with gonadotropinomas in relation to the immunoreactivity of pituitary adenoma.
    Pawlikowski Łódź M; Jaranowska M; Fryczak J; Radek M; Świętosławski J; Kunert-Radek J; Winczyk K
    Endokrynol Pol; 2018; 69(5):526-529. PubMed ID: 30074232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
    Ferone D; Lastoria S; Colao A; Varrella P; Cerbone G; Acampa W; Merola B; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro.
    Klibanski A; Alexander JM; Bikkal HA; Hsu DW; Swearingen B; Zervas NT
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1248-55. PubMed ID: 1720125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma alpha-subunit levels during the treatment of pituitary adenomas with the somatostatin analog (SMS 201-995).
    Sassolas G; Serusclat P; Claustrat B; Trouillas J; Merabet S; Cohen R; Souquet JC
    Horm Res; 1988; 29(2-3):124-8. PubMed ID: 2456975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture.
    Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.
    Saveanu A; Gunz G; Dufour H; Caron P; Fina F; Ouafik L; Culler MD; Moreau JP; Enjalbert A; Jaquet P
    J Clin Endocrinol Metab; 2001 Jan; 86(1):140-5. PubMed ID: 11231991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycoprotein hormone alpha-subunit secretion in non-functioning pituitary adenomas].
    Góth M; Szabolcs I; Czirják S; Hubina E; Kovács L; Dohán O; Szilágyi G
    Orv Hetil; 1997 Oct; 138(42):2655-9. PubMed ID: 9411334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.
    Beck-Peccoz P; Piscitelli G; Amr S; Ballabio M; Bassetti M; Giannattasio G; Spada A; Nissim M; Weintraub BD; Faglia G
    J Clin Endocrinol Metab; 1986 Apr; 62(4):704-11. PubMed ID: 2419356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P; Díez JJ
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.